InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Ellis Andrea, 董事. Insider active across 1 company, notably BridgeBio Pharma, Inc.. Cumulatively, 9 reports have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €1.4m. Activity tracked since 15 March 2022. The latest transaction was filed on 9 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Ellis Andrea is Administrateur and Director at BridgeBio Pharma, Inc. The record shows 9 filings in total, and across the 9 sampled filings between 2022-03-17 and 2026-07-13, the reported amounts include EUR 92002 of buys and EUR 1261919 of sells, with Levée d'options as the most frequent transaction nature.